Prosecution and licensing of patents and utility models, including opposition and appeal proceedings before the European Patent Office and the national patent courts; patent infringement litigation, including opinions on the validity and the scope of patents such as freedom-to-operate and due- diligence analysis in a variety of technical fields, in particular gene technology, biochemistry, molecular biology, gene therapy, biotechnology, cell biology, immunology, virology, pharmaceutical and organic chemistry,   DNA arrays, medical devices, chemical engineering.

Recently, Thomas Friede successfully defended a patent relating to a therapeutic substance before a Board of Appeal of the European Patent Office while another important case related to a diagnostic assay. In a current case, Thomas Friede is part of a BARDEHLE PAGENBERG team of patent attorneys and attorneys-at-law litigating a medical device patent of a US manufacturer.

Thomas Friede regularly publishes articles on his fields of practice in legal and business journals (see publications).

1993-1996	Research biochemist at the German Cancer Research Center, Heidelberg in the fields of molecular immunology and autoimmune diseases
1997-2000	Trainee in two German patent law firms
2001-2002	Trainee at the District Court Munich, German Patent and Trademark Office and Federal Patent Court
2002-2004	Associate of the firm Grünecker, Kinkeldey, Stockmair & Schwanhäusser, Munich
since 2004	Associate of the firm "Bardehle, Pagenberg, Dost, Altenburg, Geissler", Munich

1987-1993	Studies of Biochemistry at the University of Tübingen
1993	Diploma in Biochemistry
1996	Degree of Dr.rer.nat. (Ph.D.) at the University of Tübingen
2002	Admitted as German Patent Attorney and European Patent Attorney

German, English, French